DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Vandetanib
Vandetanib
Vandetanib (rINN, proposed trade name Zactima), also known as ZD6474, is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR). It is a tyrosine kinase inhibitor, being developed by AstraZeneca. It has a third target: inhibiting RET-tyrosine kinase activity, an important growth driver in certain types of thyroid cancer
Vandetanib - List of case studies
- Drugs
-
Valerian Valproate Valproic acid Vandetanib Vasodilators Velcade Venofen Verapamil ...
- Papillary Carcinoma of Thyroid with Multiple and Diffuse Nodular Secondarisms of the Pulmonary Parenchyma
-
cancer not responsive to radioiodine treatment, such as vandetanib, sorafenib, motesanib, sunitinib, abitins or similar? Do you think ... , Rosoglitazone, Oral Antidiabetic medications, vandetanib, sorafenib, motesanib, sunitinib, abitins, Adriamycin, ...